← Evidence map

ArticleHealth psychology research2022

Viloxazine for the Treatment of Attention Deficit Hyperactivity Disorder.

Christopher L Robinson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36168642